MALDI-TOF and cluster-TOF-SIMS imaging of Fabry disease biomarkers

[1]  D. Touboul,et al.  Structural analysis of secondary ions by post-source decay in time-of-flight secondary ion mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[2]  Kees Jalink,et al.  Gold-enhanced biomolecular surface imaging of cells and tissue by SIMS and MALDI mass spectrometry. , 2006, Analytical chemistry.

[3]  David Touboul,et al.  Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source , 2005, Journal of the American Society for Mass Spectrometry.

[4]  Jonathan V Sweedler,et al.  Vitamin E imaging and localization in the neuronal membrane. , 2005, Journal of the American Chemical Society.

[5]  D. Touboul,et al.  Biological tissue imaging with time-of-flight secondary ion mass spectrometry and cluster ion sources. , 2005, Journal of mass spectrometry : JMS.

[6]  K. Mills,et al.  Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry. , 2005, Molecular genetics and metabolism.

[7]  F. Halgand,et al.  Lipid imaging by gold cluster time-of-flight secondary ion mass spectrometry: application to Duchenne muscular dystrophy Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M500058-JLR200 , 2005, Journal of Lipid Research.

[8]  Sandrine Roy,et al.  Fast fingerprinting by MALDI–TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease , 2005, Analytical and bioanalytical chemistry.

[9]  B. Plecko,et al.  Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry using stearoyl-d35-globotriaosylceramide as internal standard. , 2005, Rapid communications in mass spectrometry : RCM.

[10]  Sander R Piersma,et al.  Subcellular imaging mass spectrometry of brain tissue. , 2005, Journal of mass spectrometry : JMS.

[11]  A. Altelaar,et al.  Direct molecular imaging of Lymnaea stagnalis nervous tissue at subcellular spatial resolution by mass spectrometry. , 2005, Analytical chemistry.

[12]  M. Simionescu,et al.  Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction , 2005, Journal of cellular and molecular medicine.

[13]  R. Schiffmann,et al.  Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: An arterial spin tagging study , 2004, Journal of magnetic resonance imaging : JMRI.

[14]  A. Das,et al.  Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. , 2004, Molecular genetics and metabolism.

[15]  J. Lausmaa,et al.  Surface chemical analysis of carbohydrate materials used for chromatography media by time-of-flight secondary ion mass spectrometry. , 2004, Analytical chemistry.

[16]  A. Mehta,et al.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey , 2004, European journal of clinical investigation.

[17]  F. Halgand,et al.  Tissue molecular ion imaging by gold cluster ion bombardment. , 2004, Analytical chemistry.

[18]  Dean Billheimer,et al.  Integrating histology and imaging mass spectrometry. , 2004, Analytical chemistry.

[19]  Yuko Higashi,et al.  Cholesterol sulfate in human physiology: what's it all about? , 2003, Journal of lipid research.

[20]  Michelle L. Reyzer,et al.  Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. , 2003, Journal of mass spectrometry : JMS.

[21]  Nicholas Lockyer,et al.  A C60 primary ion beam system for time of flight secondary ion mass spectrometry: its development and secondary ion yield characteristics. , 2003, Analytical chemistry.

[22]  S. Packman,et al.  Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy , 2003, Annals of Internal Medicine.

[23]  R. Dwek,et al.  Glucosylceramide modulates membrane traffic along the endocytic pathway Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200232-JLR200 , 2002, Journal of Lipid Research.

[24]  G. Bartolucci,et al.  Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease. , 2002, Rapid communications in mass spectrometry : RCM.

[25]  R. Desnick,et al.  Fabry Disease: Twenty Novel α-Galactosidase A Mutations and Genotype-Phenotype Correlations in Classical and Variant Phenotypes , 2002, Molecular medicine.

[26]  K. Mills,et al.  Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry , 2002, FEBS letters.

[27]  R. Bateman,et al.  Ionization and fragmentation of neutral and acidic glycosphingolipids with a Q-TOF mass spectrometer fitted with a MALDI ion source , 2001, Journal of the American Society for Mass Spectrometry.

[28]  M. Gladwin,et al.  Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy , 2001, Circulation.

[29]  P. Chaurand,et al.  Organic ion imaging of biological tissue with secondary ion mass spectrometry and matrix-assisted laser desorption/ionization. , 2001, Journal of mass spectrometry : JMS.

[30]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[31]  K. Simons,et al.  Jamming the endosomal system: lipid rafts and lysosomal storage diseases. , 2000, Trends in cell biology.

[32]  N. Huh,et al.  Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: a review. , 2000, Mutation research.

[33]  V. Puri,et al.  Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases , 1999, Nature Cell Biology.

[34]  M. Patterson,et al.  Broad screening test for sphingolipid-storage diseases , 1999, The Lancet.

[35]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.

[36]  G. Fields,et al.  Promotion of Fibroblast Adhesion by Triple-helical Peptide Models of Type I Collagen-derived Sequences (*) , 1996, The Journal of Biological Chemistry.

[37]  D. Wink,et al.  Modulation of Superoxide-dependent Oxidation and Hydroxylation Reactions by Nitric Oxide (*) , 1996, The Journal of Biological Chemistry.

[38]  B. Halliwell,et al.  Nitric oxide and oxygen radicals: a question of balance , 1995, FEBS letters.

[39]  S. Della-Negra,et al.  Impact of slow gold clusters on various solids: nonlinear effects in secondary ion emission , 1991 .

[40]  Koichi Tanaka,et al.  Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry , 1988 .

[41]  M. Karas,et al.  Matrix-assisted ultraviolet laser desorption of non-volatile compounds , 1987 .

[42]  T. Igarashi,et al.  Effect of vitamin E and ticlopidine on platelet aggregation in Fabry's disease , 1987, Clinical genetics.

[43]  R. McCluer,et al.  Fabry disease , 1982, Neurology.

[44]  M. Breimer,et al.  Negative electrospray ionization mass spectrometry analysis of gangliosides, sulphatides and cholesterol 3‐sulphate , 1995 .

[45]  Jeanette Adams,et al.  Structure-specific collision-induced fragmentations of ceramides cationized with alkali-metal ions , 1993 .

[46]  C. Costello,et al.  Tandem mass spectrometry of glycolipids. , 1990, Methods in enzymology.

[47]  A. Benninghoven,et al.  Tandem Mass Spectrometer for Secondary Ion Studies , 1971 .